Business Wire

MA-TA-ASSOCIATES

8.1.2018 08:02:03 CET | Business Wire | Press release

Share
TA Associates Announces 2018 Global Staff Promotions

TA Associates, a leading global growth private equity firm, today announced promotions earned by six investment staff members in TA’s Boston, Menlo Park and London offices, effective January 1, 2018.

“It is an honor to recognize the well-deserved promotions of these talented and dedicated team members who have each played a vital role in generating significant value for our investors, portfolio companies and TA,” said Brian J. Conway, Chairman and Managing Partner at TA Associates. “We look forward to their continued contributions as we seek growth investment opportunities and work with the management teams of our portfolio companies to reach their full potential.”

Patrick Sader was promoted to Managing Director from Director. He is based in the London office of TA Associates (UK), LLP, focusing on investments in consumer, financial and business services companies across Europe and heading the firm’s effort in France. Mr. Sader led TA’s investments in Babilou, CIPRÉS, Hana Group, Kiwoko and Zadig & Voltaire, and was actively involved in the firm’s investment in DNCA Finance. Mr. Sader serves on the Board of Directors of Babilou, Hana Group, Kiwoko and Zadig & Voltaire, and formerly served on the Board of CIPRÉS. Prior to joining TA in 2011, Mr. Sader was a Director at Argan Capital and a Senior Associate at Terra Firma Capital Partners. He also worked in the M&A Financial Institutions Group of Merrill Lynch. Mr. Sader received a BA degree in Finance and Accounting from ESSEC Business School.

Max Cancre was promoted to Senior Vice President from Vice President. He is based in the London office of TA Associates (UK), LLP, focusing on investments in technology and data services companies across Europe. Mr. Cancre is a Board Observer of Interswitch and ITRS. He was also actively involved in TA’s investments in 10bis, DNCA Finance and Zadig & Voltaire. Prior to joining TA in 2010, Mr. Cancre worked in the Investment Banking Division, Structured Finance Group at Barclays Capital. He received a BA degree in Economics and International Relations from the University of Pennsylvania and an MBA from the Harvard Business School.

John W. DiCola was promoted to Senior Vice President from Vice President. He is based in TA’s Boston office, focusing on investments in technology companies in North America. Mr. DiCola serves on the Board of Directors of Radixx International and was also actively involved in TA’s investments in Insurity and TierPoint. Prior to joining TA in 2015, he was an Associate at Hellman & Friedman, LLC and an Analyst at Greenhill & Co. Mr. DiCola received a BA in Economics from Stanford University and an MBA from the Harvard Business School.

Lovisa Lander was promoted to Senior Vice President from Vice President. She is based in the London office of TA Associates (UK), LLP, focusing on investments in the healthcare and education sectors across Europe, as well as cross-sector Nordic investments. Ms. Lander is a Board Observer of Biocomposites and PhysIOL, formerly served on the Board of Directors of Cath Kidston and was a Board Observer of Internationella Engelska Skolan. She was also actively involved in TA’s investments in Inspired, Kiwoko, Söderberg & Partners and Zadig & Voltaire. Prior to joining TA in 2010, Ms. Lander worked in the Investment Banking Division, Consumer Products and Retail Group at Rothschild. She received an MSc degree in Technology Management and Economics from Chalmers University of Technology.

Alex Melamud was promoted to Senior Vice President from Vice President. He is based in TA’s Menlo Park office, focusing on investments in technology and technology-enabled services companies in North America. Mr. Melamud serves on the Board of Directors of Arxan Technologies and Gamma Technologies, is a Board Observer of Maintenance Connection and Mitratech, and was also actively involved in TA’s investments in Aicent, CyOptics, DigiCert and MicroSeismic. Prior to joining TA in 2009, he worked in the Global Technology Investment Banking Group at Barclays Capital. Mr. Melamud received a BS degree, summa cum laude, in Business Administration and a BA degree, summa cum laude, in Psychology from the University of Southern California, and an MBA from the Stanford Graduate School of Business.

Amara Suebsaeng was promoted to Senior Vice President from Vice President. She is based in TA’s Boston office, focusing on investments in business, technology-enabled, information and other services companies in North America. Ms. Suebsaeng serves on the Board of Directors of OMNIA Partners and was also actively involved in TA’s investments in Cosentry and MicroSeismic. Prior to joining TA in 2010, Ms. Suebsaeng worked in the Investment Banking Division, Global Power and Utilities Group at Morgan Stanley. Ms. Suebsaeng received a BA degree, Phi Beta Kappa, magna cum laude, in Economics from Princeton University and an MBA, with Distinction, from the Harvard Business School. She is an Overseer of Boston Ballet.

About TA Associates

TA Associates is one of the largest and most experienced global growth private equity firms. Focused on five target industries – technology, healthcare, financial services, consumer and business services – TA invests in profitable, growing companies with opportunities for sustained growth, and has invested in nearly 500 companies around the world. Investing as either a majority or minority investor, TA employs a long-term approach, utilizing its strategic resources to help management teams build lasting value in growth companies. TA has raised $24 billion in capital and is investing out of current funds of $7.25 billion. The firm’s more than 85 investment professionals are based in Boston, Menlo Park, London, Mumbai and Hong Kong. More information about TA Associates can be found at www.ta.com .

Contact:

TA Associates
Marcia O’Carroll, 617-574-6796
mocarroll@ta.com
or
BackBay Communications
Zachary Tramonti, 617-391-0797
zachary.tramonti@backbaycommunications.com
or
Stephen Fishleigh, +44 203 475 7552
stephen.fishleigh@backbaycommunications.com

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release

The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye